ABSTRACT
Hypoxic-ischemic encephalopathy (HIE) is a common cause of neonatal encephalopathy
and is one of the most important causes of neonatal death and disabilities, especially
those infants with moderate to severe encephalopathy. However, the pathogenesis of
HIE still remains unclear. The purpose of this study was to explore the dynamic changes
in plasma neuropeptide Y (NPY) and neurotensin (NT) as well as their role in regulating
cerebral hemodynamics in HIE patients. The plasma levels of NPY and NT in the umbilical
artery and peripheral blood on the first, third, and seventh days after birth in 40
term infants with HIE and 40 healthy controls were measured using radioimmunoassay.
On the first day of life, the blood samples were collected immediately when ultrasound
examinations were finished. The ultrasound transducer was placed on the temporal fontanelle
to detect the hemodynamic parameters of the middle cerebral artery, including peak
systolic flow velocity, end-diastolic flow velocity, time-average mean velocity, pulsatility
index, and resistance index (RI) in both groups were measured by pulse Doppler ultrasound
in the first day after birth. The relationship between RI and NPY or NT was analyzed
by linear regression analysis. NPY levels in umbilical blood ([mean ± standard deviation]
615.5 ± 130.7 ng/L) and first-day peripheral blood (355.9 ± 57.4 ng/L) in neonates
with HIE were significantly higher than those in normal newborns’ blood (199.1 ± 63.2
and 214.4 ± 58.0 ng/L, respectively; p < 0.01). NPY levels in HIE neonates then declined to control levels on the third
day after birth (p > 0.05). However, the levels of plasma NT in umbilical blood and peripheral blood
were much higher in the HIE group than those in normal newborns during the first week
(p < 0.01). The results of Doppler ultrasound examinations showed that cerebral blood
flow velocity significantly decreased, whereas RI increased markedly in HIE patients
compared with healthy controls (p < 0.01). Linear regression analysis revealed that the RI was positively correlated
with NPY levels (r = 0.614; p < 0.01) and negatively correlated with NT levels (r = -0.579; p < 0.01). The results of this study showed that there was a significant increase in
plasma NPY and NT levels in HIE patients and this was strongly related to the severity
of HIE, and the hemodynamic parameter RI was significantly correlated with NPY and
NT. Therefore, we believe that the dynamic changes in plasma NPY or NT levels participate
in the mechanisms of HIE by regulating cerebral hemodynamic changes after neonatal
asphyxia occurs.
KEYWORDS
Neonate - hypoxic-ischemic encephalopathy - neuropeptide Y - neurotensin - cerebral
hemodynamics
REFERENCES
1
Ferriero D M.
Neonatal brain injury.
N Engl J Med.
2004;
351
1985-1995
2
Perlman J M.
Summary proceedings from the neurology group on hypoxic-ischemic encephalopathy.
Pediatrics.
2006;
117
S28-S33
3
Shah P, Riphagen S, Beyene J, Perlman M.
Multiorgan dysfunction in infants with post-asphyxia hypoxic-ischaemic encephalopathy.
Arch Dis Child Fetal Neonatal Ed.
2004;
89
F152-F155
4
Liu J, Li J, Gu M.
The correlation between myocardial function and cerebral hemodynamics in term infants
with hypoxic-ischemic encephalopathy.
J Trop Pediatr.
2007;
53
44-48
5
Feng G Z, Feng X, Yang L et al..
Plasma neuropeptide Y level in neonates with asphyxia.
Zhongguo Dang Dai Er Ke Za Zhi.
2003;
5
314-316
6
Antonelli T, Ferraro L, Fuxe K et al..
Neurotensin enhances endogenous extracellular glutamate levels in primary cultures
of rat cortical neurons: involvement of neurotensin receptor in NMDA induced excitotoxicity.
Cereb Cortex.
2004;
14
466-473
7
Suzuki Y, Sato S, Suzuki H et al..
Increased neuropeptide Y concentrations in cerebrospinal fluid from patients with
aneurysmal subarachnoid hemorrhage.
Stroke.
1989;
20
1680-1684
8
Juul R, Edvinsson L, Fredriksen T A et al..
Changes in the levels of neuropeptide Y-LI in the external jugular vein in connection
with vasoconstriction following subarachnoid haemorrhage in man: involvement of sympathetic
neuropeptide Y in cerebral vasospasm.
Acta Neurochir (Wien).
1990;
107
75-81
9 Taeusch H W, Ballard R A. Avery’s Diseases of the Newborn. 7th ed. Philadelphia;
Elsevier Saunders 1999: 855
10
Liu J, Cao H Y, He C Y et al..
Hemodynamics of multiple organs in asphyxiated neonates.
Zhonghua Er Ke Za Zhi.
1998;
36
69-73
11
Liu J, Cao H Y, Huang X H, Wang Q.
The pattern and early diagnostic value of Doppler ultrasound for neonatal hypoxic-ischemic
encephalopathy.
J Trop Pediatr.
2007 June 7 (Epub ahead of print);
12
Ilves P, Talvik R, Talvik T.
Changes in Doppler ultrasonography in asphyxiated term infants with hypoxic-ischaemic
encephalopathy.
Acta Paediatr.
1998;
87
680-684
13
Dumont Y, Martel J C, Fournier A et al..
Neuropeptide Y and neuropeptide Y receptor subtypes in brain and peripheral tissues.
Prog Neurobiol.
1992;
38
125-167
14
Glass M J, Chan J, Pickel V M.
Ultrastructural localization of neuropeptide Y Y1 receptors in the rat medial nucleus tractus solitarius: relationships with neuropeptide
Y or catecholamine neurons.
J Neurosci Res.
2002;
67
753-765
15
Adrian T E, Allen J M, Bloom S R et al..
Neuropeptide Y distribution in human brain.
Nature.
1983;
306
584-586
16
Minson J B, Llewellyn-Smith I J, Pilowsky P M et al..
Bulbospinal neuropeptide Y-immunoreactive neurons in the rat: comparison with adrenaline-synthesizing
neurons.
J Auton Nerv Syst.
1994;
47
233-243
17
Tseng C J, Lin H C, Wang S D et al..
Immunohistochemical study of catecholamine enzymes and neuropeptide Y in the rostral
ventrolateral medulla and bulbospinal projection.
J Comp Neurol.
1993;
334
294-303
18
Michalkiewicz M, Zhao G, Jia Z et al..
Central neuropeptide Y signaling ameliorates N (omega)-nitro-L-arginine methyl ester hypertension in the rat through a Y1 receptor mechanism.
Hypertension.
2005;
45
780-785
19
Matsumura K, Tsuchihashi T, Abe I.
Central cardiovascular action of neuropeptide Y in conscious rabbits.
Hypertension.
2000;
36
1040-1044
20
Emson P C, Goedert M, Horsfield P et al..
The regional distribution and chromatographic characterisation of neurotensin-like
immunoreactivity in the rat central nervous system.
J Neurochem.
1982;
38
992-999
21
Mai J K, Triepel J, Metz J.
Neurotensin in the human brain.
Neuroscience.
1987;
22
499-524
22
López Ordieres M G, Rodríguez de Lores Arnaiz G.
Neurotensin effect on Na+ -K+ -ATPase is CNS area- and membrane-dependent and involves high affinity NT1 receptor.
Neurochem Res.
2002;
27
1555-1561
23
Katz L M, Wang Y F, McMahon B et al..
Neurotensin analog NT69L induces rapid and prolonged hypothermia after hypoxic ischemia.
Acad Emerg Med.
2001;
8
1115-1121
24
Katz L M, Young A, Frank J E et al..
Neurotensin-induced hypothermia improves neurologic outcome after hypoxic-ischemia.
Crit Care Med.
2004;
32
806-810
25
Chen S H, Cheung R T.
Intracerebroventricular injection of a neuropepptide Y-Y1 receptor agonist increases while BIBP3226, a Y1 antagonist, reduces the infarct volume following transient middle cerebral artery
occlusion in rates.
Neuroscience.
2003;
116
119-126
26
Torup L, Borsdal J, Sager T.
Neuroprotective effect of the neurotensin analogue JMV449 in a mouse model of permanent
middle cerebral ischemia.
Neurosci Lett.
2003;
351
173-176
Jing LiuPh.D.
Department of Neonatology and NICU, Beijing Obstetrics and Gynecology Hospital, Capital
Medical University
251 Yaojiayuan Road, Chaoyang District, Beijing 100026, China